Overview
Natsuko Yamazaki practices practicing medicine in Kanazawa, Japan.
Ms. Yamazaki is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Amebiasis, Interstitial Keratitis, and Corneal Transplant.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Natsuko Yamazaki
Is Natsuko Yamazaki a top-rated expert for Amebiasis?
MediFind is an objective health platform that identifies experts based on real-world data. Natsuko Yamazaki is classified as an Advanced expert for Amebiasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Natsuko Yamazaki participate in research or clinical trials?
Yes. Natsuko Yamazaki has published 14 articles and abstracts on conditions like Amebiasis. You can view a list of Natsuko Yamazaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AmebiasisMs. Yamazaki isAdvanced. Learn about Amebiasis.
- Interstitial KeratitisMs. Yamazaki isAdvanced. Learn about Interstitial Keratitis.
- Experienced
- Corneal TransplantMs. Yamazaki isExperienced. Learn about Corneal Transplant.